Patents Assigned to Seabelife
  • SYNERGISTIC COMBINATIONS OF REGULATED NECROSIS INHIBITORS WITH N-ACETYLCYSTEINE
    Publication number: 20260263402
    Abstract: The present invention relates to relates to a pharmaceutical composition comprising a combination of N-acetylcysteine with at least one inhibitor of regulated necrotic cell death, such as necroptosis and/or ferroptosis.
    Type: Application
    Filed: December 4, 2023
    Publication date: September 10, 2026
    Applicants: Seabelife, Universite de Rennes, Institut National de la Santé et de la Recherche Médicale, Ecole des Hautes Études en Santé Publique (EHESP)
    Inventors: Mélanie SIMOES EUGENIO, Marie-Thérèse DIMANCHE-BOITREL, Sophie BELAL, Morgane ROUSSELOT
  • USE OF INDOLE, 6- AND 7-AZAINDOLE DERIVATIVES AS INHIBITORS OF FERROPTOSIS REGULATED CELL DEATH
    Publication number: 20240116923
    Abstract: The present invention relates to a compound of the following general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as drug for inhibiting ferroptosis.
    Type: Application
    Filed: January 25, 2022
    Publication date: April 11, 2024
    Applicants: Seabelife, Centre National de la Recherche Scientifique (CNRS), Sorbonne Universite, Institut National de la Santé et de la Recherche Médicale (INSERM), Université Claude Bernard Lyon 1, Universite de Rennes 1
    Inventors: Stéphane BACH, Arnaud COMTE, Claire DELEHOUZE, Marie-Thérèse DIMANCHE-BOITREL, Peter GOEKJIAN